Head-to-head · Cost-Efficiency Index
Medical Health Institute vs Neuvé Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Medical Health Institute
Shoppers comparing across TRT, peptides, and weight loss under one provider who don't need public pricing detail up front.
Visit Medical Health InstituteNeuvé Health
Readers who want the route and the base chosen explicitly and will ask what the monthly figure covers before enrolling.
Visit Neuvé HealthThe verdict
Medical Health Institute and Neuvé Health tie on the Cost-Efficiency Index at 68/100, so neither wins outright on the numbers. For most shoppers we'd start with Medical Health Institute (ranked #116, a hair above #118) — Shoppers comparing across TRT, peptides, and weight loss under one provider who don't need public pricing detail up front. But Neuvé Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Medical Health Institute.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Medical Health Institute | Neuvé Health |
|---|---|---|
| Cost-Efficiency Index | 68/100 | 68/100 |
| Semaglutide / mo | $100/mo (all doses, compounded) | $217/month (standard injectable with B12; the site gives three different answers on whether the medication is inside the figure) |
| Tirzepatide / mo | Not disclosed | $324/month (standard injectable with B12; same unresolved question about what the figure covers) |
| Semaglutide / yr (modeled) | $1,200 | $2,604 |
| Tirzepatide / yr (modeled) | — | $3,888 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #116 | #118 |
Medical Health Institute
68/100Where the value is
- Advertises a competitively low $100/mo entry price for GLP-1 weight loss
- Offers multiple service lines (weight loss, TRT, peptide therapy) under one provider
- LegitScript and HIPAA-compliance badges both displayed on the homepage
The tradeoffs
- The $100/mo headline price carries the company's own asterisk — '*Based on pharmacy availability' — meaning it is explicitly not a guaranteed rate before intake
- No dose tier or even which drug (semaglutide vs. tirzepatide) the $100 figure applies to is disclosed anywhere public
Neuvé Health
68/100Where the value is
- Prices twelve distinct GLP-1 products before any account: injectable and sublingual, standard and low dose, with a B12 or a B12-free glycine base for each
- States the 503A and 503B compounding classes on the homepage and the About page, which the August record did not find
- Names its founder as a nurse practitioner with a care role rather than referring only to an anonymous network
The tradeoffs
- Three surfaces disagree on whether the medication is inside the monthly price: the weight-loss page is headed "All-in monthly pricing" and lists the compounded drug as included, while its own fine print and the financial policy say medication, labs and supplies are billed separately
- The clinical partner that would settle that question — and that bills for the medication, the labs and the consultation — is never named
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.